Abstract
DLBCL is the most common lymphoma with high tumor heterogeneity. Treatment refractoriness and relapse from R-CHOP therapy in patients remain a clinica......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
